User:Mr. Ibrahem/Lefamulin

Lefamulin, sold under the brand name Xenleta, is an antibiotic used to treat community-acquired pneumonia. It is used when other antibiotics are not appropriate. It is effective against a number of bacteria including MRSA. It is taken by mouth or by injection into a vein.

Common side effects include diarrhea, nausea, pain at the site of injection, and liver inflammation. Other side effects may include QT prolongation and Clostridioides difficile infection. Use during pregnancy may harm the baby. It is a pleuromutilin antibiotic and works by blocking the production of proteins from bacterial RNA.

Lefamulin was approved for medical use in the United States in 2019 and Europe in 2020. In the United States a 5 day course of treatment costs about 1450 USD as of 2021. While it is approved in Europe, it is not commercially available there as of 2021.